ginkgolic-acid and Diabetes-Mellitus--Type-2

ginkgolic-acid has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for ginkgolic-acid and Diabetes-Mellitus--Type-2

Article	Year
Structure-Activity Relationship of Synthetic Ginkgolic Acid Analogs for Treating Type 2 Diabetes by PTPN9 Inhibition. International journal of molecular sciences, 2022, Apr-01, Volume: 23, Issue:7 Ginkgolic acid (C13:0) (GA), isolated from Ginkgo biloba, is a potential therapeutic agent for type 2 diabetes. A series of GA analogs were designed and synthesized for the evaluation of their structure-activity relationship with respect to their antidiabetic effects. Unlike GA, the synthetic analog Topics: Diabetes Mellitus, Type 2; Glucose; Humans; Insulin; Insulin Resistance; Muscle Fibers, Skeletal; Palmitates; Salicylates; Signal Transduction; Structure-Activity Relationship	2022

Article

Year

Structure-Activity Relationship of Synthetic Ginkgolic Acid Analogs for Treating Type 2 Diabetes by PTPN9 Inhibition.

International journal of molecular sciences, 2022, Apr-01, Volume: 23, Issue:7

Ginkgolic acid (C13:0) (GA), isolated from Ginkgo biloba, is a potential therapeutic agent for type 2 diabetes. A series of GA analogs were designed and synthesized for the evaluation of their structure-activity relationship with respect to their antidiabetic effects. Unlike GA, the synthetic analog

Topics: Diabetes Mellitus, Type 2; Glucose; Humans; Insulin; Insulin Resistance; Muscle Fibers, Skeletal; Palmitates; Salicylates; Signal Transduction; Structure-Activity Relationship

2022